These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7923245)

  • 1. Increased proliferation of a human breast carcinoma cell line by recombinant interleukin-2.
    Katano M; Matsuo T; Morisaki T; Naito K; Nagumo F; Kubota E; Nakamura M; Hisatsugu T; Tadano J
    Cancer Immunol Immunother; 1994 Sep; 39(3):161-6. PubMed ID: 7923245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2 (IL-2) production by human B-cell line.
    Katano M; Morisaki T; Matsuo T; Nakamura M; Kubota E; Hisatsugu T
    Cell Immunol; 1994 Dec; 159(2):262-70. PubMed ID: 7994758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant IL 2 but not recombinant interferon-gamma stimulates both proliferation and IgM secretion in a Ly-1+ clone of neoplastic murine B cells (BCL1).
    Brooks KH; Vitetta ES
    J Immunol; 1986 Nov; 137(10):3205-10. PubMed ID: 2945863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant human interleukin 2 (rIL-2) on normal peripheral blood B cells and B lymphoblastoid cell lines.
    Haas R; Hohaus S; Kiesel S; Ogniben E; Ehrhardt R; Hunstein W
    Immunol Lett; 1989 Sep; 22(3):239-45. PubMed ID: 2680916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-specific inhibition of bone marrow erythropoiesis by recombinant DNA-derived interleukin-2.
    Burdach SE; Levitt LJ
    Blood; 1987 May; 69(5):1368-75. PubMed ID: 3105620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human large granular lymphocyte and T cell growth and function by recombinant interleukin 2: induction of interleukin 2 receptor and promotion of growth of cells with enhanced cytotoxicity.
    Yamada S; Ruscetti FW; Overton WR; Herberman RB; Birchenall-Sparks MC; Ortaldo JR
    J Leukoc Biol; 1987 Jun; 41(6):505-17. PubMed ID: 3110337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth of MCF-7 human breast carcinoma in severe combined immunodeficient mice: growth suppression by recombinant interleukin-2 treatment and role of lymphokine-activated killer cells.
    Zhai YF; Esselman WJ; Oakley CS; Chang CC; Welsch CW
    Cancer Immunol Immunother; 1992; 35(4):237-45. PubMed ID: 1511458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiotypic immunoglobulin secretion by human B cell non-Hodgkin's lymphomas is related to the expression of the interleukin-2 receptor.
    Vyth-Dreese FA; Dellemijn TA; Hekman A; Melief CJ
    Leukemia; 1988 Apr; 2(4):231-5. PubMed ID: 3129622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 enhances the growth of human melanoma cells derived form primary but not from metastatic tumours.
    García-Vázquez MD; Boyano MD; Cañavate ML; Gardeazabal J; de Galdeano AG; López-Michelena T; Ratón JA; Izu R; Díaz-Ramón JL; Díaz-Pérez JL
    Eur Cytokine Netw; 2000 Dec; 11(4):654-61. PubMed ID: 11125310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of IL-2, IL-4 and IL-6 in the growth and differentiation of tumor-specific CD4+ T helper and CD8+ T cytotoxic cells.
    Selvan RS; Nagarkatti PS; Nagarkatti M
    Int J Cancer; 1990 Jun; 45(6):1096-104. PubMed ID: 1972141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a major 50-kDa molecular weight human B-cell growth factor with Tac antigen-inducing activity on B cells.
    Kawano M; Matsushima K; Oppenheim JJ
    Cell Immunol; 1987 Aug; 108(1):132-49. PubMed ID: 3111722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth of certain myeloid leukemic cells can be stimulated by interleukin-2.
    Tanaka M
    Growth Factors; 1991; 5(3):191-9. PubMed ID: 1777232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 2 receptor expression and interleukin 2 localisation in human solid tumor cells in situ and in vitro: evidence for a direct role in the regulation of tumour cell proliferation.
    McMillan DN; Kernohan NM; Flett ME; Heys SD; Deehan DJ; Sewell HF; Walker F; Eremin O
    Int J Cancer; 1995 Mar; 60(6):766-72. PubMed ID: 7896442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of sIL-2R alpha from and activation of native human peripheral blood mononuclear cells by recombinant IL-15.
    Treiber-Held S; Stewart DM; Barraclough HA; Kurman CC; Nelson DL
    Clin Immunol Immunopathol; 1996 Jul; 80(1):67-75. PubMed ID: 8674241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological monitoring of low-dose interleukin 2 in humans: soluble interleukin 2 receptors, cytokines, and cell surface phenotypes.
    Hänninen EL; Körfer A; Hadam M; Schneekloth C; Dallmann I; Menzel T; Kirchner H; Poliwoda H; Atzpodien J
    Cancer Res; 1991 Dec; 51(23 Pt 1):6312-6. PubMed ID: 1933892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phorbol myristate acetate-induced expression of high-affinity interleukin 2 receptors and production of interleukin 2 by human acute lymphoblastic leukemia T cells.
    Sahraoui Y; Allouche M; Perrakis M; Clemenceau C; Jasmin C; Georgoulias V
    Leukemia; 1992 Apr; 6(4):295-303. PubMed ID: 1588792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of human recombinant IL-2 on murine macrophage precursors. Involvement of a receptor distinct from the p55 (Tac) protein.
    Baccarini M; Schwinzer R; Lohmann-Matthes ML
    J Immunol; 1989 Jan; 142(1):118-25. PubMed ID: 2462585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between crude interleukin-2 and recombinant interleukin-2 in maintaining killing activity of cultured lymphocytes.
    Nakanishi M; Kan N; Okino T; Satoh K; Mise K; Teramura Y; Yamasaki S; Ohgaki K; Tobe T
    Biotherapy; 1990; 2(1):21-32. PubMed ID: 2119201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomodulation of interleukin-2 effect by L-2-oxothiazolidine-4-carboxylate on human malignant melanoma.
    del Olmo M; Alonso-Varona A; Castro B; Bilbao P; Palomares T
    Cancer Immunol Immunother; 2006 Aug; 55(8):948-57. PubMed ID: 16220324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.